Takeda to Maintain Drug Pricing Model After Trump Pressure
Japan’s largest drugmaker, Takeda Pharmaceuticals, said it will maintain its existing pricing model in the U.S., despite President Donald Trump’s call for drug companies to lower their prices.
Source: Drug Industry Daily